With the acquisition, Beiersdorf aims to strengthen its expertise in the treatment of acne. As a relatively young company in which Beiersdorf already invested back in 2018, S-Biomedic will continue to function as a separate entity and complement Beiersdorf’s research activities.
S-Biomedic conducts research on the skin’s microbiome: i.e., the variety of microorganisms than can be found on the skin. As such, the young innovative company develops active ingredients for cosmetic products, using live skin bacteria.
What’s more, S-Biomedic is based at the JLABS incubator – under the wings of pharmaceutical giant Johnson & Johnson – in Beerse (Flanders).
S-Biomedic and JLABS are just two of the many startups, incubators and other organizations that make Flanders’ ecosystem for life sciences & health so successful. Want to unravel this ecosystem in a virtual yet interactive way? Head to the Flanders360 platform and discover 300+ successful companies, universities, R&D centers and other players active in Flanders’ life sciences & health industry.
Alternatively, check out our industry overview to learn more about the available tax, legal and other incentives for establishing your life sciences & health hub in Flanders.